AUROBINDO PHARMA   
                    
                    
                                                         
                                
                                                                 Back to All Ratios 
                                                
                     | 
                        
                        
                        
                        
                    
AUROBINDO PHARMA Last 5 Year Total Debt/Equity History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt/Equity(x) | 0.24 | 0.21 | 0.18 | 0.10 | 0.23 | 
What is the latest Total Debt/Equity ratio of AUROBINDO PHARMA ?
| Year | Total Debt/Equity | 
|---|---|
| Mar2025 | 0.24 | 
| Mar2024 | 0.21 | 
| Mar2023 | 0.18 | 
| Mar2022 | 0.10 | 
| Mar2021 | 0.23 | 
How is Total Debt/Equity of AUROBINDO PHARMA Trending?
| Years | Total Debt/Equity | % Change | |
|---|---|---|---|
| Mar2025 | 0.24 | 14.29 | |
| Mar2024 | 0.21 | 16.67 | |
| Mar2023 | 0.18 | 80.00 | |
| Mar2022 | 0.1 | -56.52 | |
| Mar2021 | 0.23 | - | |
Other Financial Ratios of AUROBINDO PHARMA
| Operational &  Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate  | Margin  Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin  | Performance  Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales  | Efficiency  Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days  | Valuation  Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales  | Growth  Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth  | Financial Stability  Ratios Current Ratio Quick Ratio Interest Cover Total Debt/Mcap  | 
Compare Total Debt/Equity ratio of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹66,850.1 Cr | 5.3% | 6.5% | -19.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | 1.2% | 4.4% | -9.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,488.0 Cr | 5.8% | 19.2% | 16.3% | Stock Analytics | |
| CIPLA | ₹121,452.0 Cr | -3.7% | -0.2% | 1.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,057.0 Cr | 1.4% | 1.8% | 10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,220.0 Cr | -7.3% | -4% | -6.1% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year | 
| AUROBINDO PHARMA |    5.3%  | 
                            
                     
                     6.5%  | 
                     
                     -19.4%  | 
                    
| SENSEX |    -1.4%  |    
                      
                    
                     3.1%  | 
                     
                     3.8%  | 
                    
You may also like the below Video Courses